• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Choosing treatment for patients with ductal carcinoma in situ: fine tuning the University of Southern California/Van Nuys Prognostic Index.为导管原位癌患者选择治疗方法:对南加州大学/凡奈斯预后指数进行微调。
J Natl Cancer Inst Monogr. 2010;2010(41):193-6. doi: 10.1093/jncimonographs/lgq040.
2
Treatment selection for patients with ductal carcinoma in situ (DCIS) of the breast using the University of Southern California/Van Nuys (USC/VNPI) prognostic index.使用南加州大学/凡奈斯(USC/VNPI)预后指数对乳腺导管原位癌(DCIS)患者进行治疗选择。
Breast J. 2015 Mar-Apr;21(2):127-32. doi: 10.1111/tbj.12368. Epub 2015 Jan 20.
3
Prognostic Significance of Clinicopathologic Features in Patients With Breast Ductal Carcinoma-in-Situ Who Received Breast-Conserving Surgery.保乳手术治疗乳腺导管原位癌患者的临床病理特征的预后意义。
Clin Breast Cancer. 2018 Dec;18(6):441-450.e2. doi: 10.1016/j.clbc.2018.04.002. Epub 2018 Apr 10.
4
Application of the van nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examined by serial macroscopic sectioning: practical considerations.通过连续宏观切片检查的367例乳腺导管原位癌回顾性系列研究中Van Nuys预后指数的应用:实际考量
Breast Cancer Res Treat. 2000 May;61(2):151-9. doi: 10.1023/a:1006437902770.
5
Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery.范努伊斯预后指数在保乳手术后导管原位癌复发预测中的价值。
Br J Surg. 2003 Apr;90(4):426-32. doi: 10.1002/bjs.4051.
6
The significance of the Van Nuys prognostic index in the management of ductal carcinoma in situ.范努伊斯预后指数在导管原位癌管理中的意义。
World J Surg Oncol. 2008 Jun 18;6:61. doi: 10.1186/1477-7819-6-61.
7
Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast.乳腺导管原位癌患者同侧局部复发与治疗及形态学特征的关系
Eur J Surg Oncol. 2000 Aug;26(5):444-51. doi: 10.1053/ejso.1999.0919.
8
Effect of margins of excision on recurrence after local excision of ductal carcinoma in situ of the breast.乳腺导管原位癌局部切除术后切缘对复发的影响。
J Clin Pathol. 2002 Aug;55(8):581-6. doi: 10.1136/jcp.55.8.581.
9
Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.保乳治疗的导管原位癌患者切缘阴性的界定:芝加哥大学的经验
Breast J. 2005 Jul-Aug;11(4):242-7. doi: 10.1111/j.1075-122X.2005.21617.x.
10
259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.应用USC/范纽斯预后指数的259例乳腺导管原位癌患者:长期随访的回顾性研究
Breast Cancer Res Treat. 2008 Jun;109(3):405-16. doi: 10.1007/s10549-007-9668-7. Epub 2007 Aug 9.

引用本文的文献

1
A Nomogram Using Imaging Features to Predict Ipsilateral Breast Tumor Recurrence After Breast-Conserving Surgery for Ductal Carcinoma In Situ.基于影像学特征的列线图预测导管原位癌保乳术后同侧乳房肿瘤复发
Korean J Radiol. 2024 Oct;25(10):876-886. doi: 10.3348/kjr.2024.0268.
2
Tools to Guide Radiation Oncologists in the Management of DCIS.指导放射肿瘤学家管理导管原位癌的工具。
Healthcare (Basel). 2024 Apr 6;12(7):795. doi: 10.3390/healthcare12070795.
3
Immune cell infiltrate in ductal carcinoma in situ and the risk of dying from breast cancer: case-control study.乳腺导管原位癌中的免疫细胞浸润与乳腺癌死亡风险:病例对照研究。
Br J Surg. 2024 Jan 31;111(2). doi: 10.1093/bjs/znae037.
4
Ipsilateral tumor recurrence risk in women with ductal carcinoma in situ: application of the Van Nuys Prognostic Index and the Memorial Sloan Kettering Cancer Center nomogram.同侧肿瘤复发风险在患有导管原位癌的女性中:Van Nuys 预后指数和 Memorial Sloan Kettering 癌症中心列线图的应用。
Breast Cancer Res Treat. 2023 Nov;202(1):185-190. doi: 10.1007/s10549-023-07036-5. Epub 2023 Jul 30.
5
Adjuvant Radiation Therapy for Ductal Carcinoma In Situ of the Breast: A Clinician's Dilemma.乳腺癌导管原位癌的辅助放疗:临床医生的困境
Ann Surg Oncol. 2023 Oct;30(11):6281-6283. doi: 10.1245/s10434-023-13691-1. Epub 2023 Jun 6.
6
Associations of clinicopathological factors with local treatment and survival outcome in elderly patients with ductal carcinoma .老年导管癌患者临床病理因素与局部治疗及生存结果的相关性
Front Surg. 2023 May 5;10:1074980. doi: 10.3389/fsurg.2023.1074980. eCollection 2023.
7
Analysis of Local Recurrence Risk in Ductal Carcinoma In Situ and External Validation of the Memorial Sloan Kettering Cancer Center Nomogram.导管原位癌局部复发风险分析及纪念斯隆凯特琳癌症中心列线图的外部验证
Cancers (Basel). 2023 Apr 21;15(8):2392. doi: 10.3390/cancers15082392.
8
Treatment of Ductal Carcinoma in situ: A Register-Based Study of Norwegian Women Diagnosed between 1995 and 2018.导管原位癌的治疗:一项基于登记的对1995年至2018年间确诊的挪威女性的研究。
Breast Care (Basel). 2022 Oct;17(5):486-494. doi: 10.1159/000524564. Epub 2022 Apr 21.
9
Prediction Models and Decision Aids for Women with Ductal Carcinoma In Situ: A Systematic Literature Review.导管原位癌女性的预测模型与决策辅助工具:一项系统文献综述
Cancers (Basel). 2022 Jul 2;14(13):3259. doi: 10.3390/cancers14133259.
10
Molecular subtypes predict second breast events of ductal carcinoma in situ after breast-conserving surgery.分子亚型可预测保乳手术后导管原位癌的二次乳腺事件。
Cancer Med. 2022 Jul;11(14):2755-2766. doi: 10.1002/cam4.4651. Epub 2022 May 22.

本文引用的文献

1
Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast.乳腺导管原位癌患者标本检查方案
Arch Pathol Lab Med. 2009 Jan;133(1):15-25. doi: 10.5858/133.1.15.
2
The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast.南加州大学/凡奈斯乳腺癌导管原位癌预后指数
Am J Surg. 2003 Oct;186(4):337-43. doi: 10.1016/s0002-9610(03)00265-4.
3
A prognostic index for ductal carcinoma in situ of the breast.一种乳腺导管原位癌的预后指数。
Cancer. 1996 Jun 1;77(11):2267-74. doi: 10.1002/(SICI)1097-0142(19960601)77:11<2267::AID-CNCR13>3.0.CO;2-V.
4
Prognostic classification of breast ductal carcinoma-in-situ.乳腺导管原位癌的预后分类
Lancet. 1995 May 6;345(8958):1154-7. doi: 10.1016/s0140-6736(95)90982-6.

为导管原位癌患者选择治疗方法:对南加州大学/凡奈斯预后指数进行微调。

Choosing treatment for patients with ductal carcinoma in situ: fine tuning the University of Southern California/Van Nuys Prognostic Index.

作者信息

Silverstein Melvin J, Lagios Michael D

机构信息

Breast Program, Hoag Memorial Hospital Presbyterian, Newport Beach, CA , USA.

出版信息

J Natl Cancer Inst Monogr. 2010;2010(41):193-6. doi: 10.1093/jncimonographs/lgq040.

DOI:10.1093/jncimonographs/lgq040
PMID:20956828
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5161065/
Abstract

The University of Southern California/Van Nuys Prognostic Index is an algorithm that quantifies five measurable prognostic factors known to be important in predicting local recurrence in conservatively treated patients with ductal carcinoma in situ (tumor size, margin width, nuclear grade, age, and comedonecrosis). With three times as many patients since originally developed, sufficient numbers now exist for analysis by individual scores rather than groups of scores. To achieve a local recurrence rate of less than 20% at 12 years, these data support excision alone for all patients scoring 4, 5, or 6 and patients who score 7 but have margin widths ≥ 3 mm. Excision plus RT achieves the less than 20% local recurrence requirement at 12 years for patients who score 7 and have margins < 3 mm, patients who score 8 and have margins ≥ 3 mm, and for patients who score 9 and have margins ≥ 5 mm. Mastectomy is required for patients who score 8 and have margins < 3 mm, who score 9 and have margins < 5 mm, and for all patients who score 10, 11, or 12 to keep the local recurrence rate less than 20% at 12 years. These recommendations in this article represent substantial changes from those previously published.

摘要

南加州大学/凡奈斯预后指数是一种算法,它量化了五个可测量的预后因素,这些因素在预测经保守治疗的导管原位癌患者的局部复发中很重要(肿瘤大小、切缘宽度、核分级、年龄和粉刺样坏死)。自最初开发以来,患者数量增加了两倍,现在有足够的数量可以按个体分数而非分数组进行分析。为了在12年时使局部复发率低于20%,这些数据支持对所有得分为4、5或6分的患者以及得分为7分但切缘宽度≥3mm的患者仅进行切除。对于得分为7分且切缘<3mm的患者、得分为8分且切缘≥3mm的患者以及得分为9分且切缘≥5mm的患者,切除加放疗可在12年时达到低于20%的局部复发要求。对于得分为8分且切缘<3mm的患者、得分为9分且切缘<5mm的患者以及所有得分为10、11或12分的患者,需要进行乳房切除术,以使12年时的局部复发率低于20%。本文中的这些建议与之前发表的建议有很大变化。